High-risk additional cytogenetic aberrations in a Dutch chronic phase chronic myeloid leukemia patient population

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IVCohort Study · 2011 · 290 citations
2. 2Treatment outcome in a population-based, ‘real-world’ cohort of patients with chronic myeloid leukemiaRegistry Study · 2017 · 66 citations
3. 3Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitorsPrognostic Study · 2017 · 51 citations
4. 4Emergence of clonal cytogenetic abnormalities in Ph−cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majorityCohort Study · 2003 · 222 citations
5. 5The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome‐negative cellsCohort Study · 2007 · 130 citations